This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: University of California. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Rachelle H Crosbie: Innovator in Muscular Dystrophy Treatments
Introduction
Rachelle H Crosbie is a prominent inventor based in Los Angeles, CA. She has made significant contributions to the field of medical research, particularly in the treatment of muscular dystrophies. With a total of 2 patents, her work focuses on innovative methods and compositions that aim to improve the lives of those affected by these debilitating conditions.
Latest Patents
Crosbie's latest patents include groundbreaking research on compositions and methods for treating muscular dystrophies. The first patent discusses compounds that increase sarcospan expression, which is crucial for treating diseases related to the dysfunction of dystrophin-related complexes. The second patent outlines methods for treating and preventing muscular dystrophies by administering compounds that enhance sarcospan levels. These patents represent a significant advancement in the therapeutic approaches available for muscular dystrophy.
Career Highlights
Rachelle H Crosbie is affiliated with the University of California, where she conducts her research and develops her innovative treatments. Her work has garnered attention in the scientific community, and she continues to push the boundaries of what is possible in the realm of muscular dystrophy treatment.
Collaborations
Crosbie collaborates with esteemed colleagues, including Cynthia Shu and Varghese John. These partnerships enhance her research efforts and contribute to the development of effective treatments for muscular dystrophies.
Conclusion
Rachelle H Crosbie is a dedicated inventor whose work in the field of muscular dystrophy treatment is making a significant impact. Her innovative patents and collaborations highlight her commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
